FDA Approved: AZATHIOPRINE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for azathioprine from Rising Pharma Holdings, Inc., confirming a new generic form of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Nephrotic Syndrome
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Ulcerative Colitis

Drugs mentioned

• Azathioprine (azathioprine)

Snippet

SUPPL AP for AZATHIOPRINE (AZATHIOPRINE)